For patients with type 2 diabetes, hemoglobin A1c should be measured at baseline and approximately every 3 months until glycemic targets are achieved, then at least twice yearly if stable
To view a copy of this license, visit About this article Cite this article Lai, TT., Tsai, YH., Liou, CW
Moderately increased risk
For doses above 1,000 mcg, splitting the amount between morning and evening can help maintain more consistent blood levels and may improve overall utilization
In a clinical trial, Grigson and her colleagues tested the safety and efficacy of daily injections of a GLP-1 receptor agonist, liraglutide, in people receiving treatment for opioid use disorder
2015;6(2):e02481